BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15194049)

  • 1. Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model.
    Janát-Amsbury MM; Yockman JW; Lee M; Kern S; Furgeson DY; Bikram M; Kim SW
    Mol Ther; 2004 Jun; 9(6):829-36. PubMed ID: 15194049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment.
    Janát-Amsbury MM; Yockman JW; Lee M; Kern S; Furgeson DY; Bikram M; Kim SW
    J Control Release; 2005 Jan; 101(1-3):273-85. PubMed ID: 15588911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral delivery of p2CMVmIL-12 using water-soluble lipopolymers.
    Mahato RI; Lee M; Han S; Maheshwari A; Kim SW
    Mol Ther; 2001 Aug; 4(2):130-8. PubMed ID: 11482984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice.
    Li J; Dong X; Xu Z; Jiang X; Jiang H; Krissansen GW; Sun X
    J Biomed Sci; 2008 Jan; 15(1):99-109. PubMed ID: 17705027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of local, non-viral IL12 gene therapy and systemic paclitaxel chemotherapy in a syngeneic ID8 mouse model for human ovarian cancer.
    Janát-Amsbury MM; Yockman JW; Anderson ML; Kieback DG; Kim SW
    Anticancer Res; 2006; 26(5A):3223-8. PubMed ID: 17094433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.
    Gorczynski RM; Chen Z; Erin N; Khatri I; Podnos A
    PLoS One; 2014; 9(11):e113597. PubMed ID: 25409195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
    Latimer P; Menchaca M; Snyder RM; Yu W; Gilbert BE; Sanders BG; Kline K
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1244-52. PubMed ID: 19657067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis.
    Rodrigo-Garzón M; Berraondo P; Ochoa L; Zulueta JJ; González-Aseguinolaza G
    Cancer Gene Ther; 2010 Jan; 17(1):20-7. PubMed ID: 19575045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.
    Eralp Y; Wang X; Wang JP; Maughan MF; Polo JM; Lachman LB
    Breast Cancer Res; 2004; 6(4):R275-83. PubMed ID: 15217493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
    Liao Y; Zou YY; Xia WY; Hung MC
    Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles.
    Shen J; Sun H; Xu P; Yin Q; Zhang Z; Wang S; Yu H; Li Y
    Biomaterials; 2013 Feb; 34(5):1581-90. PubMed ID: 23146437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor efficacy and biodistribution of linear polyethylenimine-cholesterol/DNA complexes.
    Furgeson DY; Yockman JW; Janat MM; Kim SW
    Mol Ther; 2004 Jun; 9(6):837-45. PubMed ID: 15194050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes.
    Yockman JW; Maheshwari A; Han SO; Kim SW
    J Control Release; 2003 Feb; 87(1-3):177-86. PubMed ID: 12618034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapy.
    Kelly MP; Lee FT; Tahtis K; Smyth FE; Brechbiel MW; Scott AM
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5604s-5612s. PubMed ID: 17875796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo.
    Goto T; Nishi T; Kobayashi O; Tamura T; Dev SB; Takeshima H; Kochi M; Kuratsu J; Sakata T; Ushio Y
    Mol Ther; 2004 Nov; 10(5):929-37. PubMed ID: 15509510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-viral delivery of interleukin-2 and soluble Flk-1 inhibits metastatic and primary tumor growth in renal cell carcinoma.
    Yockman JW; Kim WJ; Chang CW; Kim SW
    Gene Ther; 2007 Oct; 14(19):1399-405. PubMed ID: 17653245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy of neural cell injuries in vitro using the hypoxia-inducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP).
    Kim JM; Lee M; Kim KH; Ha Y; Choi JK; Park SR; Park H; Park HC; Ahn CH; Kim SW; Choi BH
    J Control Release; 2009 Jan; 133(1):60-7. PubMed ID: 18938203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.
    Kelly MP; Lee FT; Smyth FE; Brechbiel MW; Scott AM
    J Nucl Med; 2006 Apr; 47(4):716-25. PubMed ID: 16595507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.
    Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F
    Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.